Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of Cash
Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...
manilatimes8h
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
"We are honored to welcome Alison to the Artiva Board of Directors. Her decades of executive experience in manufacturing and ...
Indian population saw 30% increase in ANAs post Covid-19, says study
ANAs are proteins produced by the immune system that mistakenly target the body's own cells, leading to tissue damage and ...
Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility
Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...
Scientific Research Publishing23h
DNA damage levels in systemic lupus erythematosus patients with low disease activity: An evaluation by comet assay ()
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease ... metabolites during a one-year period among asymptomatic subjects. Journal of Clinical Medicine and Research, 4, 52-55. [14] ...